News & Events

OpSens INTEGRATES ITS OPTOWIRE’S dPR AND FFR ALGORITHMS WITHIN CATHMEDICAL CARDIOVASCULAR’s PICASSO SYSTEM IN SPAIN Agreement Allows Cardiologists to Perform dPR and FFR Procedures Using OpSens’ OptoWire and Cathmedical’s Picasso System in an Integrated Fashion Quebec City, Quebec, April 21, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company, today announced…

Read more

  OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues Quebec City, Quebec, April 14, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the second quarter of fiscal…

Read more

OPSENS AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III  Contract awarded for products that bring improvement to health care industry   Quebec City, Quebec, April 7, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company, announced today it has been awarded an Innovative Technology  contract from Vizient, Inc.,…

Read more

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, April 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical…

Read more